Michael Scolaro

Michael Scolaro

Aug 22, 2017

Group 6 Copy 36
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can viral molecular structures cause cancer?

    Epstein-Barr virus (EBV) infects 9 out of 10 people and can lead to cancers such as Hodgkin's, Burkitt's...

    The Down Low: Curbing the HIV Epidemic in Rural Louisiana

    African American men who have sex with men (MSMs) are at higher risk for new HIV infections in rural communities...

    Will vitamin D improve the health of patients with heart failure?

    We are trying to determine if supplemental vitamin D in heart failure patients will improve heart function...

    Backer Badge Funded